The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
5-hydroxybenzo[b]furan-2-yl-(5-hydroxy-1Hindol-2-yl)methanone ID: ALA226184
PubChem CID: 44423636
Max Phase: Preclinical
Molecular Formula: C17H11NO4
Molecular Weight: 293.28
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2o1
Standard InChI: InChI=1S/C17H11NO4/c19-11-1-3-13-9(5-11)7-14(18-13)17(21)16-8-10-6-12(20)2-4-15(10)22-16/h1-8,18-20H
Standard InChI Key: ZKIUEEGLQKCTHN-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 25 0 0 0 0 0 0 0 0999 V2000
10.3338 -19.8043 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.3303 -20.6317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0439 -21.0466 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.0468 -19.3936 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7610 -19.8048 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7589 -20.6313 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5443 -20.8887 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.0318 -20.2213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5477 -19.5515 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8568 -20.2234 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2675 -20.9389 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
14.2711 -19.5099 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.0901 -19.4277 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.9358 -18.7574 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5502 -18.2069 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2621 -18.6233 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9766 -18.2150 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.9803 -17.3904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2636 -16.9759 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5521 -17.3866 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2640 -16.1509 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6204 -19.3900 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5 6 1 0
10 11 2 0
10 12 1 0
12 13 1 0
2 3 1 0
3 6 2 0
13 16 1 0
15 14 1 0
14 12 2 0
1 2 2 0
5 4 2 0
15 16 2 0
6 7 1 0
16 17 1 0
7 8 1 0
17 18 2 0
8 9 2 0
18 19 1 0
9 5 1 0
19 20 2 0
20 15 1 0
4 1 1 0
19 21 1 0
8 10 1 0
1 22 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 293.28Molecular Weight (Monoisotopic): 293.0688AlogP: 3.56#Rotatable Bonds: 2Polar Surface Area: 86.46Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 3#RO5 Violations (Lipinski): ┄CX Acidic pKa: 9.20CX Basic pKa: ┄CX LogP: 2.92CX LogD: 2.92Aromatic Rings: 4Heavy Atoms: 22QED Weighted: 0.49Np Likeness Score: -0.15
References 1. Mahboobi S, Uecker A, Cénac C, Sellmer A, Eichhorn E, Elz S, Böhmer FD, Dove S.. (2007) Inhibition of FLT3 and PDGFR tyrosine kinase activity by bis(benzo[b]furan-2-yl)methanones., 15 (5): [PMID:17210255 ] [10.1016/j.bmc.2006.12.011 ]